This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MiPLA: Difference between revisions
>RoRoKey pharmacology |
>RoRoKey m minor spacing |
||
| Line 17: | Line 17: | ||
==Pharmacology== | ==Pharmacology== | ||
As with its structurally related Lysergamides, MiPLA principally acts as a 5-HT2A partial agonist, through which it exerts its psychedelic effects. | As with its structurally related Lysergamides, MiPLA principally acts as a 5-HT2A partial agonist, through which it exerts its psychedelic effects. | ||
However, the role of these interactions and how they result in the psychedelic experience continues to remain an object of scientific elucidation. | However, the role of these interactions and how they result in the psychedelic experience continues to remain an object of scientific elucidation. | ||